Science
-
CORTELLIS FOR COMPETITIVE INTELLIGENCE
Accurate & timely competitive intelligence insights to grow your business.
-
New Global Research Report: United Kingdom
Outstanding research performance outpaces private-sector investment
-
Publisher Relations
A new webpage provides easy access to information on our Journal, Books and Conference Proceedings Selection, Master Lists and Submissions Process.
Drug Reports from Cortellis for Competitive Intelligence
Thomson Reuters Cortellis for Competitive Intelligence is an intuitive intelligence tool with access to a huge database of drug pipelines, deals, patents, companies, and the latest industry news. Learn more by previewing sample drug reports and sign-up for a free two week trial.
Over 40,000 drug reports are available in Thomson Reuters Cortellis for Competitive Intelligence, such as Erlotinib (Tarceva), Etanercept (Enbrel), Imatinib (Gleevec), Infliximab (Remicade) and Pregabalin (Lyrica).
Special Topic of Supersymmetry
Since the 1980s, if not earlier, supersymmetry has reigned as the best available candidate for physics beyond the standard model's theory of almost everything that would unite the weak, strong, and electromagnetic interactions in one global formulation, while predicting an entire universe of as-yet-undiscovered elementary particles. In this analysis, ScienceWatch Special Topics examines the literature on supersymmetry over the past decade and over the past two years. Learn more about the Special Topic of supersymmetry...
Latest Press Releases
Join our partner program
Learn more about how to become a partner and our partnership categories.
Master Journal List
Search over 16,000 journal titles covered in our scientific products.